Artivion, Inc. (AORT) Stock Price

AORTStock

$21.78−47.57%52W

Market Cap$1.06B

P/E108.71x

PEG Ratio—

Div yield—

Beta1.31

AORT Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-52.51%

Price vs S&P 500 (4W)-6.50%

VGM Score45.36

P/E Ratio (Annual)108.71x

P/CF (Annual)26.63x

Book Value / Share (Quarterly)$9.15

P/TBV (Annual)7.41x

Revenue Growth (3Y)12.04%

Cash Flow / Share (Quarterly)$-0.19

Price vs S&P 500 (YTD)-64.17%

Gross Margin (TTM)64.37%

Net Profit Margin (TTM)-0.67%

EPS (TTM)$-0.07

10-Day Avg Trading Volume0.51M

EPS Excl Extra (TTM)$-0.07

Revenue Growth (5Y)11.75%

EPS (Annual)$0.21

ROI (Annual)1.46%

Gross Margin (Annual)64.40%

Net Profit Margin (5Y Avg)-4.20%

Cash / Share (Quarterly)$1.59

P/E Basic Excl Extra (TTM)117.64x

Revenue Growth QoQ (YoY)11.32%

P/E Normalized (Annual)108.71x

ROA (Last FY)1.10%

Revenue Growth TTM (YoY)16.40%

EBITD / Share (TTM)$0.58

ROE (5Y Avg)-5.05%

Operating Margin (TTM)2.89%

Cash Flow / Share (Annual)$0.02

P/B Ratio2.38x

P/B Ratio (Quarterly)2.45x

Net Income / Employee (Annual)$5,400

EV / Revenue (TTM)2.87x

Net Interest Coverage (TTM)1.79x

ROA (TTM)-0.34%

EV / EBITDA (TTM)47.04x

EPS Incl Extra (Annual)$0.21

Current Ratio (Annual)3.53x

Quick Ratio (Quarterly)2.26x

3-Month Avg Trading Volume0.68M

52-Week Price Return-47.57%

EV / Free Cash Flow (Annual)1611.06x

P/E Incl Extra (TTM)117.64x

Revenue / Employee (TTM)$261,900

Tangible BV / Share (Quarterly)$4.55

P/S Ratio (Annual)2.41x

Asset Turnover (Annual)0.50x

52-Week High$48.25

Operating Margin (5Y Avg)2.27%

EPS Excl Extra (Annual)$0.21

CapEx CAGR (5Y)39.74%

26-Week Price Return-42.61%

Quick Ratio (Annual)2.20x

13-Week Price Return-13.09%

Total Debt / Equity (Annual)0.49x

Current Ratio (Quarterly)3.47x

Enterprise Value$1.35B

Revenue / Share Growth (5Y)6.95%

Asset Turnover (TTM)0.51x

Book Value / Share Growth (5Y)-1.62%

Revenue / Employee (Annual)$245,200

Inventory Turnover (Annual)1.82x

Pretax Margin (Annual)3.35%

Cash / Share (Annual)$1.36

3-Month Return Std Dev36.30%

Gross Margin (5Y Avg)64.76%

Net Income / Employee (TTM)$-1,800

EBITDA CAGR (5Y)18.96%

EBITDA Interim CAGR (5Y)10.60%

ROE (Last FY)2.18%

Net Interest Coverage (Annual)1.10x

EPS Basic Excl Extra (Annual)$0.21

P/FCF (TTM)27.88x

Receivables Turnover (TTM)4.98x

EV / Free Cash Flow (TTM)105.53x

Total Debt / Equity (Quarterly)0.82x

EPS Incl Extra (TTM)$-0.07

Receivables Turnover (Annual)5.22x

ROI (TTM)-0.45%

P/S Ratio (TTM)2.25x

Pretax Margin (5Y Avg)-2.88%

Revenue / Share (Annual)$9.36

Tangible BV / Share (Annual)$6.10

Forward P/E317.25x

Free OCF CAGR (5Y)-30.14%

Price vs S&P 500 (52W)-63.10%

P/E Ratio (TTM)117.64x

Year-to-Date Return-52.25%

5-Day Price Return-0.05%

EPS Normalized (Annual)$0.21

ROA (5Y Avg)-1.77%

Net Profit Margin (Annual)2.21%

Month-to-Date Return-4.56%

Cash Flow / Share (TTM)$-0.05

EBITD / Share (Annual)$0.82

Operating Margin (Annual)5.46%

LT Debt / Equity (Annual)0.48x

P/CF (TTM)25.46x

ROI (5Y Avg)-2.32%

P/E Excl Extra (TTM)117.64x

LT Debt / Equity (Quarterly)0.82x

EPS Basic Excl Extra (TTM)$-0.07

P/TBV (Quarterly)4.92x

P/B Ratio (Annual)4.82x

Inventory Turnover (TTM)1.77x

Pretax Margin (TTM)0.47%

Book Value / Share (Annual)$9.37

Price vs S&P 500 (13W)-15.77%

Beta1.31x

P/FCF (Annual)1265.69x

Revenue / Share (TTM)$9.71

ROE (TTM)-0.71%

52-Week Low$19.16

vGradeC

gGradeC

mGradeC

vgmGradeC

AORT Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 6, 2026	$0.10	$0.13	+34.48%(+$0.03)
Q1 2026	May 7, 2026	$0.12	$0.08	-35.13%(-$0.04)
Q4 2025	Feb 12, 2026	$0.18	$0.17	-3.41%(-$0.01)
Q3 2025	Nov 6, 2025	$0.15	$0.16	+5.26%(+$0.01)
Q2 2025	Aug 7, 2025	$0.13	$0.24	+92.00%(+$0.11)

AORT Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.29

Industry Peers — Surgical & Medical Instruments(142)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
AORTArtivion, Inc.	C	C	C	2.3x	11.8%	64.4%	2.9%	$21.78
SYKStryker Corporation	C	B	C	4.4x	11.8%	65.3%	21.3%	$294.66
MMM3M Company	C	D	B	3.4x	-5.0%	39.4%	18.4%	$164.75
BSXBoston Scientific Corp.	C	B	C	3.1x	15.2%	69.5%	19.8%	$44.39
BDXBecton, Dickinson and Co.	B	D	A	2.5x	6.3%	46.7%	9.6%	$191.75
MDLNMedline Inc. Class A common stock	C	D	C	1.6x	—	26.2%	6.0%	$35.96
RMDResMed Inc.	C	C	B	5.9x	12.1%	61.1%	33.4%	$238.97
DXCMDexCom, Inc.	C	B	B	6.5x	19.3%	64.3%	22.9%	$86.04
WSTWest Pharmaceutical Services, Inc.	D	C	A	8.5x	7.4%	36.8%	20.4%	$384.02
SOLVSolventum Corporation	C	C	B	1.8x	—	54.8%	23.9%	$85.81
BAXBaxter International Inc.	B	D	B	1.1x	-0.8%	30.7%	-2.3%	$25.28
PENPenumbra, Inc.	F	C	B	8.4x	20.2%	67.8%	12.4%	$320.86
GMEDGLOBUS MEDICAL INC	B	B	B	3.3x	30.1%	68.5%	20.6%	$76.71
PODDInsulet Corporation	C	A	C	3.2x	24.5%	71.1%	16.9%	$141.10
GKOSGlaukos Corporation	F	A	B	15.9x	17.7%	79.1%	-31.6%	$164.84
TFXTeleflex Incorporated	B	F	B	2.1x	-4.7%	53.8%	-11.7%	$130.43
HAEHaemonetics Corporation	C	C	A	4.0x	8.9%	59.1%	11.9%	$118.28
MMSIMerit Medical Systems Inc	C	B	B	3.4x	9.5%	49.5%	12.8%	$89.20
STVNStevanato Group S.p.A.	D	C	C	3.7x	12.4%	29.9%	16.4%	$18.90
MMEDMiniMed Group, Inc. Common Stock	—	—	B	—	—	—	—	$17.49
HTFLHeartflow, Inc. Common Stock	F	A	A	19.8x	—	80.1%	-40.8%	$48.29
ICUIICU Medical Inc	C	D	B	1.9x	11.9%	39.1%	3.5%	$162.99
IRTCiRhythm Holdings, Inc. Common Stock	D	B	C	4.3x	23.0%	71.5%	-3.0%	$108.66
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	2725.9x	—	0.3%	-7007.8%	$44.43
ATRCAtriCure, Inc.	D	B	A	5.0x	20.9%	76.3%	2.3%	$56.07
UFPTUFP Technologies Inc	C	B	A	3.6x	27.4%	28.5%	15.3%	$291.67
INSPInspire Medical Systems, Inc.	B	B	B	2.2x	51.2%	86.1%	6.0%	$68.79
LMATLeMaitre Vascular, Inc.	C	B	C	7.0x	14.0%	72.9%	29.5%	$80.82
NVCRNovoCure Limited Ordinary Shares	D	C	C	2.3x	5.8%	76.1%	-22.1%	$14.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	15.2x	—	53.9%	-140.4%	$27.24
ATECAlphatec Holdings, Inc.	D	B	C	2.0x	39.5%	70.8%	-7.5%	$10.46
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	B	—	—	—	—	$12.29
TNDMTandem Diabetes Care, Inc.	D	C	C	1.1x	15.3%	56.0%	-4.4%	$16.24
IRMDiRadimed Corporation	D	B	B	13.1x	21.4%	75.9%	31.9%	$88.27
IARTIntegra LifeSciences Holdings	B	F	C	0.6x	3.6%	57.2%	4.0%	$13.21
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	3.0x	109.0%	64.2%	-33.9%	$17.57
BVSBioventus Inc. Class A Common Stock	B	C	A	1.9x	12.1%	68.7%	10.0%	$13.30
BBNXBeta Bionics, Inc. Common Stock	D	A	C	7.4x	—	58.3%	-69.8%	$16.35
SIBNSI-BONE, Inc. Common Stock	D	B	B	4.1x	22.3%	79.5%	-8.3%	$19.68
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	—	—	—	—	$24.00
MDXGMiMedx Group, Inc	C	D	C	1.8x	11.0%	78.8%	2.5%	$4.43
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	2.3x	27.2%	73.7%	-11.9%	$21.95
TCMDTactile Systems Technology, Inc.	B	B	B	1.5x	12.0%	51.9%	10.0%	$22.52
SSIISS Innovations International Inc. Common Stock	F	A	D	9.7x	—	47.6%	-16.2%	$2.53
DCTHDelcath Systems Inc	D	C	B	5.1x	120.1%	87.0%	-1.9%	$14.08
ANGOAngioDynamics, Inc.	C	D	C	1.5x	1.9%	55.6%	-11.2%	$11.24
BWAYBrainsway Ltd. American Depositary Shares	D	B	B	9.5x	12.2%	74.9%	5.8%	$11.44
SGHTSight Sciences, Inc. Common Stock	D	B	A	5.5x	22.9%	88.4%	-33.4%	$8.28
CERSCerus Corp	D	C	C	1.8x	15.4%	57.2%	-0.7%	$2.18
NPCENeuropace, Inc. Common Stock	D	C	C	4.3x	19.4%	79.6%	-15.3%	$12.24
RCELAvita Medical, Inc. Common Stock	D	C	A	5.3x	19.6%	82.1%	-46.6%	$13.04

About Artivion, Inc.

Artivion provides cardiac and vascular surgeons with aortic-centric surgical solutions, including heart valves, stent grafts, patches, and surgical sealants. The company operates through two segments: Medical Devices (implantable products and surgical tools) and Preservation Services (tissue preservation). With global operations across North America, EMEA, LATAM, and APAC, North America represents its largest revenue source.

AORT Next Earnings Report

Report dateNov 5, 2026

QuarterQ3 2026

Report timeAMC

EPS estimate$0.07

Revenue estimate$120.93M

Also reporting on Nov 5, 2026

Scheduled date with consensus estimates — both can change before the company reports.

Earnings calendar for November 2026

AORT Insider Transactions

SellSep 10, 2026
GREEN ANDREW M
Officer
Shares: 11,480Value: $286,656
SellSep 3, 2026
GREEN ANDREW M
Officer
Shares: 8,003Value: $216,337
SellAug 19, 2026
MACKIN JAMES PATRICK
Chief Executive Officer
Shares: 70,000Value: $2.03M
SellAug 14, 2026
BERRY LANCE A
Chief Operating Officer
Shares: 715Value: $20,413
SellAug 14, 2026
GREEN ANDREW M
Officer
Shares: 616Value: $17,586

Open-market buys and sells filed with the SEC over the last 90 days. Grants, gifts and option exercises are excluded.

All insider transactions for September 2026

Companies in Related Industries

LYNXLyntris Inc.Defense Systems & Equipment
ENOVEnovis CorporationOrthopedic & Prosthetic Devices
CDRECadre Holdings, Inc.Orthopedic & Prosthetic Devices
STAAStaar Surgical CoOphthalmic Goods
CBLLCeriBell, Inc. Common StockElectromedical Equipment
KODKEASTMAN KODAK COMPANYPhotographic Equipment & Supplies
INMDInMode Ltd. Ordinary SharesElectromedical Equipment
TRNSTranscat IncInstruments for Measuring

Same SIC sector, outside this company's own industry.

Analyst Sentiment

4.3

Strong Buy

Consensus rating

52-Week Range

Low$19.16

High$48.25